Morgan Stanley Downgrades Zenas Biopharma (ZBIO) to Equalweight
Tweet Send to a Friend
(Updated - January 5, 2026 3:41 PM EST)
Morgan Stanley analyst Sean Laaman downgraded Zenas Biopharma (NASDAQ: ZBIO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Sean Laaman downgraded Zenas Biopharma (NASDAQ: ZBIO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
